Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy
- 31 March 2021
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 30 (5) , 529-541
Abstract
Derived from genetic alterations, cancer neoantigens are proteins with novel amino acid sequences that can be recognized by the immune system. Recent evidence demonstrates that cancer neoantigens r...Keywords
Funding Information
- Patronage of HM the king
This publication has 87 references indexed in Scilit:
- Pathways of Antigen ProcessingAnnual Review of Immunology, 2013
- Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumorsJournal of Translational Medicine, 2013
- Isolation and Generation of Human Dendritic CellsCurrent Protocols in Immunology, 2012
- Developing mRNA-vaccine technologiesRNA Biology, 2012
- Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cellsBreast Cancer Research and Treatment, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Exploiting the Mutanome for Tumor VaccinationCancer Research, 2012
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral ImmunityCancer Research, 2010
- Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injectionVaccine, 2010
- Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsJournal of Experimental Medicine, 2010